home All News open_in_new Full Article

India’s Biocon Aims to Lead Copycat Wegovy Sales in Canada From Next Year

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key markets as it races to be among the first few to reap a windfall after patents on the blockbuster weight-loss drugs expire next year.


today 7 h. ago attach_file Other

attach_file Other
attach_file Economics
attach_file Other
attach_file Culture
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Economics


ID: 2074712197
Add Watch Country

arrow_drop_down